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Abstract 
 
Objective: To report outcome of monochorionic (MC) and dichorionic (DC) triamniotic 
(TA) triplet pregnancies treated with endoscopic laser coagulation of communicating 
placental vessels for severe fetofetal transfusion syndrome (FFTS) and selective fetal 
growth restriction (sFGR).  
 
Methods: Laser surgery was performed at 18 (15-24) weeks´ gestation in 11 MCTA 
and 33 DCTA pregnancies complicated by FFTS and 14 DCTA pregnancies 
complicated by sFGR. Data from our study and previous reports were pooled using 
meta-analytic techniques. 
 
Results: Survival of at least one baby and survival among all fetuses was 97.0% and 
72.7% in DCTA pregnancies with FFTS, 78.6% and 52.4% in DCTA pregnancies with 
sFGR and 81.8% and 39.4% in MCTA pregnancies with FFTS. In the combined data 
from our study and previous reports, the pooled survival rates in 132 DCTA 
pregnancies with FFTS were 94.4% and 76.1% and in 29 MCTA pregnancies with 
FFTS were 80.6% and 57.5%. 
 
Conclusions: Survival after laser surgery is higher in DC triplets with FFTS than those 
with sFGR and in DC than MC triplets with FFTS.  
Introduction 
 
Monochorionic (MC) pregnancies are often complicated by severe fetofetal 
transfusion syndrome (FFTS) and / or selective fetal growth restriction (sFGR). The 
established treatment of choice in the management of severe FFTS in MC twin 
pregnancies is endoscopic laser coagulation of the inter-twin communicating 
placental vessels [1-3]. In sFGR with abnormal Doppler findings in the umbilical artery 
of the affected fetus, there is a high risk of perinatal death and handicap for both twins; 
the management for affected pregnancies presenting at mid-gestation includes 
endoscopic laser coagulation of the inter-twin communicating placental vessels or 
cord occlusion of the FGR twin [4-8]. Few studies in a small number of patients have 
reported on endoscopic laser coagulation of communicating placental vessels for the 
management of FFTS in MC or dichorionic (DC) triamniotic (TA) triplet pregnancies 
complicated by FFTS [9-16]. 
 
The objectives of this study are to report our experience with endoscopic laser surgery 
in the management of severe FFTS or sFGR in MC and DC triplet pregnancies and 
compare the results with those of previous studies. 
 
 
Methods  
 
Study design and participants 
 
This was a retrospective study of all cases of MCTA and DCTA triplet pregnancies 
treated by endoscopic laser coagulation of communicating placental vessels at 15-24 
weeks’ gestation in our fetal medicine centre between 1996, four years after we first 
introduced endoscopic laser surgery in twins [1], and June 2015. Umbilical cord 
occlusion was not a treatment option for sFGR or FFTS in our centre. The cases 
included 11 MCTA and 33 DCTA pregnancies complicated by FFTS and 14 DCTA 
pregnancies complicated by sFGR without coexisting FFTS.  
 
Chorionicity and amnionicity were established in the first trimester as previously 
reported [17]. Gestational age was calculated from the crown-rump length of the 
biggest fetus [18]. The diagnosis of FFTS was made if there was a marked 
discordance in amniotic fluid volume between the MC fetuses with deepest vertical 
pool of <2 cm in at least one sac and >8 cm in the other; the severity of the disease 
was classified as stage I if the Doppler findings in the umbilical artery and ductus 
venosus of both fetuses were normal and the bladder of the donor was visible, stage 
II with normal Doppler findings but not visible bladder, stage III with abnormal 
Doppler findings in either of the MC fetuses and stage IV with presence of ascites or 
hydrops in either MC fetus [19].  
 
In the DCTA pregnancies, diagnosis of sFGR was based on the demonstration that 
firstly, the abdominal circumference at <22 weeks or estimated fetal weight at >22 
weeks was below the 5th percentile of the appropriate reference range [20-22] and 
secondly, the inter-twin discordance in estimated fetal weight (weight difference 
divided by the weight of the large twin) was >25%; the estimated fetal weight at <20 
weeks was derived by the formula by Warsof et al, [23] and at >20 weeks it was 
derived by the formula of Hadlock et al, [21]. In all of our cases of sFGR there was 
Doppler evidence of absent or reversed end diastolic flow (AREDF) in the umbilical 
artery of the small fetus and they were therefore classified as type II [24].  
 
Endoscopic laser surgery was carried out transabdominally using a semi-rigid 2.0 
mm diameter fetoscope (Karl Storz Gmbh, Tuttlingen, Germany), through a 3.3 mm 
diameter cannula (Cook Medical, Bloomington, Indiana, USA), after the 
administration of prophylactic antibiotics and local anesthesia. In DC triplet 
pregnancies with TTTS or sFGR the fetoscope was introduced into the sac of the 
larger fetus of the MC pair; a 400 µm diameter Nd:YAG laser fibre (Dornier Med Tech, 
Wessling, Germany) and power output of 40 W was used to coagulate the inter-twin 
communicating placental vessels as previously described for MC twin pregnancies 
[7]. In MC triplet pregnancies with TTTS the fetoscope was introduced into the sac of 
the recipient fetus and laser was used to coagulate the vessels between this fetus 
and each of the other two fetuses; subsequently, the fetoscope was advanced 
through the inter-twin membrane into the sac of one of the other fetuses to coagulate 
the vascular connections between them. In cases of polyhydramnios, amnioreduction 
was undertaken through the cannula over a period of 10-15 minutes to obtain 
subjective normalization of the amniotic fluid volume. After a period of rest for one to 
three hours, the patients were discharged home. Follow up and management of the 
pregnancies was usually undertaken in the referral hospitals. 
 
Maternal demographic characteristics, ultrasound findings and details of intrauterine 
intervention were recorded in a database. Pregnancy outcomes were collected into 
the same database when they became available from the referring hospitals, general 
practitioners or from the patients themselves. 
 
Comparison and synthesis with results from previous studies 
 
Searches of PubMed and Medline (August 2015) were performed to identify all 
studies in the English language that reported on the use of endoscopic laser surgery 
for at least two triplet pregnancies. The inclusion criteria were DCTA or MCTA 
pregnancies complicated by FFTS and / or sFGR, treated by endoscopic laser and 
providing outcome data. In case of data duplication or overlap, only the largest or 
most recent study with available data was included.  
 
Statistical analysis 
 
Data from our study and previous reports were pooled using meta-analytic 
techniques. Random effects models were used to estimate weighted neonatal 
survival rates, with 95% confidence interval (CI). Heterogeneity between studies was 
analyzed using both Higgins’ I2 and Cochrane’s Q-test [25,26].  
 
The statistical software package SPSS 20.0 (IBM SPSS Statistics for Windows, 
Version 20.0. Armonk, NY: IBM Corp) and StatsDirect Version 2.0 (Statsdirect 
Statistical Software. England. 2013) were used for data analysis.  
 
 
Results 
 
Study population 
 
During the study period of 1996 to 2015, we performed endoscopic laser coagulation 
of communicating placental vessels in 47 DCTA and 11 MCTA triplet pregnancies. 
The DCTA pregnancies included 14 with sFGR type II and 33 with FFTS; in the latter 
group, the Quintero stage was I in one, II in two, III in 29 and IV in one. In all MCTA 
pregnancies the FFTS was stage III or IV; in 6 cases there was one donor and one 
recipient, in 4 cases there were two donors and one recipient and in 1 case there 
was one donor and two recipients. 
 
DCTA triplet pregnancies with FFTS 
 
In the group of 33 DCTA triplet pregnancies with FFTS, endoscopic laser surgery 
was performed successfully in all cases at a median gestational age of 18 (range 15-
23) weeks (Table 1). There was survival to discharge from hospital in 72.7% babies 
and there was at least one survivor in 97.0% of the pregnancies. The median 
gestational age at delivery of live births was 29 weeks and 68.8% were born at <32 
weeks. 
 
In 15 pregnancies all three babies survived after delivery at 8-16 weeks following 
laser surgery. In 10 pregnancies two babies survived. In 8 cases the donor triplet 
died either in utero or in the neonatal period at 1-14 weeks after laser surgery; the 
recipient triplet and the separate one were live born and survived. In 1 case, selective 
fetocide of the donor twin was carried out by intracardiac injection of potassium 
chloride immediately after the laser ablation at 17 weeks’ gestation because, at 
presentation, this fetus was found to have ventriculomegaly and hyperechogenicity of 
the cerebral cortex; the other two babies were born 13 weeks later and survived. In 
another case, treated at 20 weeks’ gestation, selective fetocide of the separate fetus 
was carried out because of the diagnosis of cerebellar atrophy after presentation with 
ruptured membranes at 29 weeks’ gestation; the other two babies were live born and 
survived. In 7 pregnancies both MC twins died, 6 within two weeks and 1 four weeks 
after laser surgery; in these cases the separate triplet was live born and survived. In 
1 pregnancy all three babies died; the MC pair died two weeks after laser and this 
was followed by spontaneous birth at 25 weeks’ gestation of the separate triplet that 
died in the neonatal period.  
 
Long term follow up was obtained from 70 of the 72 survivors at a median of 4 (range 
1-10) years. In 69 there was normal neurodevelopment; in one ex recipient born at 
36 weeks’ gestation there is speech delay at the age of 5 years.  
 
DCTA triplet pregnancies with sFGR 
 
In the group of 14 DCTA triplet pregnancies with sFGR, endoscopic laser surgery 
was performed successfully in all cases at a median gestational age of 18 (range 16-
24) weeks (Table 1). There was survival to discharge from hospital in 52.4% babies 
and there was at least one survivor in 78.6% of the pregnancies. The median 
gestational age at delivery of live births was 32 weeks and 45.5% were born at <32 
weeks. 
 
In 1 pregnancy all three babies survived after delivery at 32 weeks’ gestation 
following laser surgery at 18 weeks. In 9 pregnancies the FGR triplet died within two 
weeks of laser surgery, but the other two babies were live born 6-20 weeks later and 
survived. In 1 pregnancy the MC twins died one week after laser surgery at 17 
weeks; the separate triplet was live born at 37 weeks and survived. In 3 pregnancies 
all three babies died; in the first case there was miscarriage within one week of laser 
surgery, in the second case the MC pair died within two weeks after laser and this 
was followed by miscarriage of the separate triplet three weeks later and in the third 
case the pregnancy progressed uneventfully after laser surgery at 17 weeks’ 
gestation but all three fetuses died after prelabor amniorrhexis and chorioamnionitis 
at 28 weeks. 
 
Long term follow up was obtained from 20 of the 22 survivors and they all had normal 
neurodevelopment at a median of 4.5 years (range 1 month to 9 years). 
 
MCTA triplet pregnancies 
 
In the group of 11 MCTA triplet pregnancies, there were 6 cases with one donor and 
one recipient, 6 cases with two donors and one recipient and 1 case with one donor 
and two recipients. In the first 4 cases of the series, there was laser coagulation of 
the communicating vessels between the recipient triplet and the other two fetuses. In 
the subsequent 8 cases, after completion of the first step as above, the fetoscope 
was advanced through the inter-twin membrane into the sac of one of the other 
fetuses to coagulate the vascular connections between them. 
 
Endoscopic laser surgery was performed at a median gestational age of 18 (range 
16-23) weeks (Table 1). There was survival to discharge from hospital in 33.3% 
babies and there was at least one survivor in 81.8% of the pregnancies. The median 
gestational age at delivery of live births was 32 weeks and 66.7% were born at <32 
weeks. 
 
In 1 pregnancy all three babies survived after delivery at 30 weeks’ gestation 
following laser surgery at 19 weeks. In 2 pregnancies the donor triplet died within two 
weeks of laser surgery at 16 and 20 weeks’ gestation, respectively, but the other two 
babies were live born 14 and 8 weeks later and survived. In 6 pregnancies there was 
only one survivor; donor and recipient triplets died within four weeks after laser 
surgery. In 2 pregnancies all three babies died; there was miscarriage within one 
week of laser surgery. 
 
Long term follow up was obtained from 11 of the 13 survivors at a median of 4.3 
(range 2.5-9) years. In 10 there was normal neurodevelopment; in 1 ex donor born at 
28 weeks’ gestation there was moderate neurodevelopmental delay at the age of 2.5 
years.  
 
Comparison of survival between the triplet pregnancies 
 
Survival of at least one baby in the DCTA pregnancies with FFTS (97.0%) was not 
significantly different from that in DCTA pregnancies with sFGR (78.6%, p=0.790) or 
MCTA pregnancies with FFTS (81.8%, p=0.276). Overall survival for all fetuses in the 
DCTA pregnancies with FFTS (72.7%) was significantly higher than in DCTA 
pregnancies with sFGR (52.4%, p=0.003) or MCTA pregnancies with FFTS (33.3%, 
p<0.0001).  
 
Synthesis with results from previous studies  
 
The literature search identified eight previous studies reporting data on DCTA 
pregnancies with FFTS treated by endoscopic laser surgery and the combined data 
from these studies with ours are shown in Table 2 and Figure 1 [9-16]. In a total of 
132 such pregnancies, the pooled survival rate of at least one baby was 94.4% (95% 
CI 90.1-97.6%) and the overall survival for all babies was 76.1 (95% CI 71.9-80.2%); 
there was no significant heterogeneity between the studies. Delivery in live births at 
<32 weeks’ gestation occurred in 56.7% (43.1-69.8%) of cases. 
 
The literature search identified five previous studies reporting data on MCTA 
pregnancies with FFTS treated by endoscopic laser surgery and the combined data 
from these studies with ours are shown in Table 3 and Figure 2 [10-13,15]. In a total 
of 29 such pregnancies, the pooled survival rate of at least one baby was 80.6% 
(95% CI 64.9-92.4%) and the overall survival for all babies was 57.5% (95% CI 36.2-
77.4%); there was significant heterogeneity between the studies. Delivery in live 
births at <32 weeks’ gestation occurred in 65.4% (47.7-81.1%) of cases. 
 
 
Discussion 
 
The findings of this study demonstrate the feasibility of endoscopic laser coagulation 
of communicating placental vessels in the treatment of MC and DC triplet 
pregnancies complicated by severe FFTS or sFGR. In DC triplets the separate fetus 
can pose some technical problems in selecting the appropriate site of entry of the 
fetoscope but in general these problems can easily be overcome; consequently, the 
outcome of affected pregnancies either by FFTS or sFGR is similar to that in MC 
twins but with an inevitable higher incidence of early preterm birth. In contrast, in MC 
triplets endoscopic laser surgery can be technically difficult because of the necessity 
to coagulate the communicating placental vessels between all three fetuses; as a 
result of such technical problems or the inability to achieve the objective of complete 
separation between all fetuses the outcome is poorer than in DC triplets.  
 
We obtained long term outcome for most survivors and recorded normal 
neurodevelopment from 89 of the 90 survivors from DC triplet pregnancies 
complicated by FFTS or sFGR and 10 of 11 from the MC triplet pregnancies. 
However, our follow up was not based on a formal assessment utilizing validated 
tools at a specific age.  
 
In the combined data from this and previous studies, in DC triplets with FFTS, there 
was survival of at least one baby in about 95% of pregnancies and survival of 75% of 
all babies. These results are compatible with those of endoscopic laser surgery in 
MC twins with severe FFTS. However, in the triplet pregnancies, a very high 
proportion of survivors, about 60%, were born at <32 weeks’ gestation. We have 
previously reported that in trichorionic triplet pregnancies with three live fetuses at 10-
14 weeks’ gestation that were managed expectantly, 35% delivered at <33 weeks; the 
rate in DC triplet pregnancies managed expectantly was 46% [27]. The higher rate of 
preterm birth in DC triplets complicated by severe FFTS and treated by endoscopic 
laser surgery is not surprising. 
 
In our DC triplets with sFGR type II there was survival of at least one baby in 79% of 
pregnancies and survival of 52% of all babies. These results are compatible with 
findings in our series of 547 MC twin pregnancies with sFGR type II treated with 
endoscopic laser surgery; there was survival of at least one baby in 72% of 
pregnancies and 54% of all babies survived [7]. In the DC triplets with sFGR type II, 
46% of survivors were born at <32 weeks’ gestation. A likely explanation for this 
lower rate of early preterm birth than in our DC triplets with FFTS treated with 
endoscopic laser (46% vs. 69%) is that following laser surgery 93% of pregnancies 
with sFGR continued to delivery with only one or two live fetuses, whereas in those 
with FFTS the equivalent rate was 54%; consequently, in relation to preterm birth, 
only 7% in the sFGR group vs 46% in the FFTS group behaved as triplet 
pregnancies. 
 
In MC triplets with severe FFTS, in comparison to DC triplets with FFTS, survival was 
poorer. In our MC triplets, at least one baby survived in 82% of pregnancies and 33% 
of all babies survived, compared to the respective rates of 97% and 73% in our 
series of DC triplets. The number of MC triplets is too small for definite conclusions to 
be drawn, but it is certain that endoscopic laser surgery in these pregnancies is 
considerably more difficult than in DC triplets. 
 
The results from endoscopic laser surgery in triplet pregnancies in our series and 
those from previous smaller studies allow some general conclusions to be drawn on 
the effectiveness of such therapy and overall survival rates. However, the total 
number of cases is still too small to allow accurate assessment of outcome according 
to subgroups of triplets, including MC and DC complicated by FFTS and / or sFGR, 
different stages of FFTS, gestational age at therapy or techniques of endoscopic 
laser surgery.  
Figure Legends  
 
Figure 1. Pooled estimates of rates of at least one survivor and survival among all 
babies in dichorionic triplet pregnancies treated with laser coagulation of placental 
vessels for feto- fetal transfusion syndrome.  
 
Figure 2. Pooled estimates of rates of at least one survivor and survival among all 
babies in monochorionic triplet pregnancies treated with laser coagulation of 
placental vessels for feto- fetal transfusion syndrome.  
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Table 1. Outcome of our triplet pregnancies treated by endoscopic laser surgery. 
 
 
DCTA = dichorionic triamniotic; MCTA = monochorionic triamniotic; TTTS = twin-to-
twin transfusion syndrome; sFGR = selective fetal growth restriction; GA = 
gestational age.  
Outcome measure DCTA, TTTS 
(n=33) 
DCTA, sFGR 
(n=14) 
MCTA, TTTS 
(n=11) 
GA at laser in w, median (range) 18 (15-23) 18 (16-24) 18 (16-23) 
Survival, n (%)    
  Three 15 (45.5) 1 (7.1) 1 (9.1) 
  Two 10 (30.3) 9 (64.3) 2 (18.2) 
  One 7 (21.2) 1 (7.1) 6 (54.5) 
> one 32 (97.0) 11 (78.6) 9 (81.8) 
  Overall 72 (72.7) 22 (52.4) 13 (39.4) 
GA at delivery of live births in w    
  Median (range) 29 (24-36) 32 (28-36) 32 (28-42) 
  <32 w, n/N (%) 22/32 (68.8) 5/11 (45.5) 6/9 (66.7) 
Table 2. Studies reporting on endoscopic laser surgery for fetofetal transfusion syndrome in dichorionic triamniotic triplet pregnancy 
 
Author Period 
Gestation at laser, 
median (range) 
Total 
(n) 
Stage 3/4, 
n (%) 
Survival of >1 baby, 
n/N (%, 95% CI) 
Overall survival 
n/N (%, 95% CI) 
Live birth at <32w 
n/N (%, 95% CI) 
Van Schoubroeck et al., 2004 [9] 1996-2002 20 (18-23) 5 5 (100) 5/5 (100, 47.8-100) 12/15 (80.0, 51.9-95.7) 4/5 (80.0, 28.4-99.5) 
De Lia et al., 2009 [11] 1992-2008 21 (18-25) 8 7 (87.5) 8/8 (100, 63.1-100) 20/24 (83.3, 62.6-95.3) 2/8 (25.0, 3.2-65.1) 
Chmait et al., 2010 [12] 1998-2008 20 (16-24) 40 26 (65.0) 37/40 (92.5, 79.6-98.4) 92/120 (76.7, 68.1-83.9) Not known 
Diemert et al., 2010 [13] 2004-2008 20 (17-23) 13 9 (69.2) 11/13 (84.6, 54.5-98.1) 27/36 (75.0, 57.8-87.9) 7/11 (63.6, 30.8-89.1) 
Peeters et al., 2012 [14] 2000-2012 18 (15-25) 8 4 (50.0) 8/8 (100, 63.1-100) 19/24 (79.2, 57.8-92.9) 4/8 (50.0, 15.7-84.3) 
Argoti et al., 2014 [15] 2005-2011 20 (15-25) 16 13 (81.2) 16/16 (100, 79.4-100) 39/48 (81.3, 67.4-91.1) Not known 
Ishi et al., 2014 [16] 2007-2013 21 (16-25) 9 6 (66.7) 9/9 (100, 66.4-100) 20/27 (74.1, 53.7-88.9) 4/9 (44.4, 13.7-78.8) 
Our study* 1996-2015 18 (15-23) 33 30 (90.9) 32/33 (97.0, 84.2-100) 72/99 (72.7, 62.9-81.2) 22/32 (68.8, 50.0-83.9) 
Pooled analysis, %, (95% CI)  132  126/132 (94.4, 90.1-97.6) 301/393 (76.1, 71.9-80.2) 43/73 (56.7, 43.1-69.8) 
Cochrane’s Q (P value)    4.3230 (0.7419) 2.0919 (0.9546) 6.8491 (0.2321) 
I2 statistic, [(%), 95% CI]    0 (0-56.3) 0 (0-56.3) 27 (0-70.7) 
 
* Including data from Sepulveda et al [10]; CI = Confidence intervals. 
 
Table 3. Studies reporting on endoscopic laser surgery for fetofetal transfusion syndrome in monochorionic triamniotic triplet pregnancy 
 
Author Period 
Gestation at laser, 
median (range) 
Total 
(n) 
Stage 3/4, 
n (%) 
Survival of >1 baby, 
n/N (%, 95% CI) 
Overall survival 
n/N (%, 95% CI) 
Live birth at <32w 
n/N (%, 95% CI) 
De Lia et al., 2009 [11] 1992-2008 21 (18-25) 2 1 (50.0) 1/2 (50.0, 1.3-98.7) 3/6 (50.0, 11.8-88.2) 1/2 (50.0, 1.3-98.7) 
Chmait et al., 2010 [12] 1998-2008 19 (17-22) 6 2 (33.3) 5/6 (83.3, 35.9-99.6) 11/18 (61.1, 35.7-82.7) 4/5 (80.0, 28.4-99.5) 
Diemert et al., 2010 [13] 2004-2008 19 (18-20) 3 1 (33.3) 2/3 (66.7, 9.4-99.2) 5/9 (55.6, 21.2-86.3) 1/2 (50.0, 1.3-98.7) 
Ishi et al., 2014 [15] 2007-2013 20 (17-22) 7 4 (57.1) 7/7 (100, 59.0-100) 18/21 (85.7, 63.7-97.0) 5/7 (71.4, 29.0-96.3) 
Our study* 1996-2015 18 (16-23) 11 11 (100.0) 9/9 (81.8, 48.2-97.7) 11/33 (33.3, 18.0-51.8) 6/9 (66.7, 29.9-92.5) 
Pooled analysis, %, (95% CI)  29  24/29 (80.6, 64.9-92.4) 48/87 (57.5, 36.2-77.4) 17/25 (65.4, 47.7-81.1) 
Cochrane’s Q (P value)    4.3804 (0.3570) 15.9245 (0.0031) 0.9285 (0.9204) 
I2 statistic, [(%), 95% CI]    8.7 (0-67.1) 74.9 (6.1-87.9) 0 (0-64.4) 
 
* Including data from Sepulveda et al [10]; CI = Confidence intervals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
